MONDAY, OCTOBER 23, 2017

Cyclospora outbreak up to 307 cases in Texas

Cyclospora cayetanensis Read More »

Imaxio announces use of antigen re-engineering in TB vaccine trial

Imaxio SA, a French biopharmaceutical company, recently announced that its proprietary pro-immunogenic technology was administered for the first time to humans in a Phase I clinical trial for a tuberculosis vaccine candidate. Read More »

Simian foamy virus found to be passed from monkeys to humans

A research team from the University of Washington, Fred Hutchinson Cancer Research Center and Jahangirnagar University announced on Wednesday that they found humans in Bangladesh who were infected with strains of the simian foamy virus. Read More »

Microneedle influenza vaccine shows 100 percent efficacy

Influenza Read More »

Merck's Durham facility receives FDA approval to manufacture bulk varicella

Merck, a global healthcare company, recently announced that its Durham, North Carolina-based facility received U.S. Food and Drug Administration approval to manufacture bulk varicella for use in vaccines against shingles and chickenpox. Read More »

Unique Parkinson's protein may help destroy TB-causing bacteria

Tuberculosis Read More »

Qatar reports first confirmed death from MERS coronavirus

Coronavirus Read More »

Global Green, Inc., gives Merial, Ltd., first option for license agreement

Global Green, Inc., announced on Wednesday that it signed an agreement with Merial, Ltd., to give Merial the first option to enter into a license agreement for the sale and distribution of its Salmogenic vaccine. Read More »

EU up to 106 human cases of West Nile fever

West Nile virus Read More »

Visterra presents efficacy data on influenza A investigational agent

Visterra, Inc., a developer of novel therapeutics to treat infectious diseases, announced on Monday that it recently presented data on its investigational influenza A agent during an international conference in South Africa. Read More »

New Zealand falling behind in new vaccination use

The Immunisation Advisory Centre announced on Monday that New Zealand, while closing equity gaps in immunization coverage, is falling behind other equivalent countries in new vaccine usage. Read More »

New study findings suggest Ghana initiate an iron supplementation program

Malaria Read More »

PaxVax initiates Phase III trial for oral cholera vaccine

PaxVax, Inc., a Menlo Park, California-based vaccine developer, announced on Friday that it initiated the Phase III clinical trial program for its PXVX0200 single-dose oral cholera vaccine candidate. Read More »

GAVI congratulates MSF on immunizations in Yida refugee camp

The GAVI Alliance recently congratulated Médecins Sans Frontières for starting to vaccinate children in the South Sudan-based Yida refugee camp with pneumococcal conjugate vaccines. Read More »

West Nile virus and EEE found in Rhode Island mosquitoes

Mosquito Read More »

UCLA study finds social media may help increase HIV prevention

A study conducted by researchers at the University of California in Los Angeles found that social media and online networks may increase healthy behaviors among men at risk of HIV infection. Read More »

MERS-CoV up to 114 confirmed cases

Coronavirus Read More »

Certara announces partnership with C-Path to test TB drugs

Certara, a provider of software and scientific consulting services, announced a new partnership on Tuesday with the Critical Path Institute to develop a model of the human lung for tuberculosis drug testing. Read More »

Copper found to destroy norovirus

Norovirus Read More »

Three new diagnostic tests may provide faster TB diagnoses

Tuberculosis Read More »